Home / Bendamustine / Canada
CA ATC L01AA09 · updated 2 Nov 2026
Bendamustine shortage in Canada
Is there a Bendamustine shortage in Canada?
Yes. As of 2 Nov 2026, 4 Bendamustine products are reported short in Canada, the first since 19 Jul 2022. The company estimate for the return is 28 Feb 2027. Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Ireland, Belgium, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (1 vial x 100 mg) | JAMP PHARMA CORPORATION | 19 Jul 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (1 vial x 25 mg) | JAMP PHARMA CORPORATION | 19 Jul 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TREANDA (1) discontinuation | TEVA CANADA LIMITED | not given | 28 Feb 2027 | Not stated |
| CA | TREANDA (1) discontinuation | TEVA CANADA LIMITED | not given | 28 Feb 2027 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.